Lianhua Qingwen Capsules Reduced the Rate of Severity in Patients with COVID-19: A System Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND: The rate of severity is a critical factor affecting the prognosis and mortality in coronavirus disease 2019 (COVID-19). Lianhua Qingwen capsules or granules (LQ) have been a promising Chinese patent medicine in treating infectious diseases and recommended for treating COVID-19. This meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chengqian, Wu, Mizhi, Yang, Kepeng, Wang, Xinchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812377/
https://www.ncbi.nlm.nih.gov/pubmed/35126606
http://dx.doi.org/10.1155/2022/9617429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812377/
https://www.ncbi.nlm.nih.gov/pubmed/35126606
http://dx.doi.org/10.1155/2022/9617429

Ejemplares similares